Year: 2013
Type: article
Abstract: Recent advances in RNA sequencing (RNA-Seq) have enabled the discovery of novel transcriptomic variations that are not possible with traditional microarray-based methods. Tissue and cell specific transcriptome changes during pathophysiological stress in disease cases versus controls and in response to therapies are of particular interest to investigators studying cardiometabolic diseases. Thus, knowledge on the relationships between sequencing depth and detection of transcriptomic variation is needed for designing RNA-Seq experiments and for interpreting results of analyses. Using deeply sequenced Illumina HiSeq 2000 101 bp paired-end RNA-Seq data derived from adipose of a healthy individual before and after systemic administration of endotoxin (LPS), we investigated the sequencing depths needed for studies of gene expression and alternative splicing (AS). In order to detect expressed genes and AS events, we found that ∼100 to 150 million (M) filtered reads were needed. However, the requirement on sequencing depth for the detection of LPS modulated differential expression (DE) and differential alternative splicing (DAS) was much higher. To detect 80% of events, ∼300 M filtered reads were needed for DE analysis whereas at least 400 M filtered reads were necessary for detecting DAS. Although the majority of expressed genes and AS events can be detected with modest sequencing depths (∼100 M filtered reads), the estimated gene expression levels and exon/intron inclusion levels were less accurate. We report the first study that evaluates the relationship between RNA-Seq depth and the ability to detect DE and DAS in human adipose. Our results suggest that a much higher sequencing depth is needed to reliably identify DAS events than for DE genes.
Source: PLoS ONE
Institution: University of Pennsylvania
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,382
Funders: University of Pennsylvania, National Institutes of Health, National Heart, Lung, and Blood Institute, National Human Genome Research Institute, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Research Resources, National Center for Advancing Translational Sciences
Awards: Mentored Patient Oriented Research in Cardiometabolic Disease, Translational Studies of ADAMTS7 a Novel GWAS Locus for Coronary Atherosclerosis, Glycomics of Heart and Lung Disease in the Genomic Era, G3340927746, Predoctoral Training Program in Genetics, G453267231, Elucidation of Tissue-Specific Transcriptomic Profiles in Cardio-metabolic Disease, Fractalkine in Adipose Inflammation and Insulin Resistance, G6412643361, Statistical Methods for Gene Mapping Studies in Admixed Populations, Developing Statistical Methods for Disease Gene Discovery, Lipids as Modulators of the Response to Vascular Injury, Institutional Clinical and Translational Science Award
OpenAlex ID: W2013990566